1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
hollywood1450@yahoo.ca
insider
Articles 

Amia Capital LLP Buys Intra-Cellular Therapies Inc, Arvinas Inc, Scholar Rock Holding Corp, Sells iShares J.P. Morgan USD Emerging Markets Bond ETF, Liberty SiriusXM Group, Liberty SiriusXM Group

Investment company Amia Capital LLP (Current Portfolio) buys Intra-Cellular Therapies Inc, Arvinas Inc, Scholar Rock Holding Corp, Molecular Templates Inc, Cidara Therapeutics Inc, sells iShares J.P. Morgan USD Emerging Markets Bond ETF, Liberty SiriusXM Group, Liberty SiriusXM Group, Petroleo Brasileiro SA Petrobras, BHP Group PLC during the 3-months ended 2020Q1, according to the most recent filings of the investment company, Amia Capital LLP. As of 2020Q1, Amia Capital LLP owns 39 stocks with a total value of $112 million. These are the details of the buys and sells.

For the details of Amia Capital LLP's stock buys and sells, go to https://www.gurufocus.com/guru/amia+capital+llp/current-portfolio/portfolio

These are the top 5 holdings of Amia Capital LLP
  1. Grifols SA (GRFS) - 1,803,856 shares, 32.38% of the total portfolio. Shares reduced by 16.41%
  2. Liberty SiriusXM Group (LSXMA) - 671,741 shares, 18.97% of the total portfolio. Shares reduced by 56.46%
  3. Liberty SiriusXM Group (LSXMK) - 398,035 shares, 11.22% of the total portfolio. Shares reduced by 58.63%
  4. BHP Group PLC (BBL) - 228,919 shares, 6.19% of the total portfolio. Shares reduced by 41.62%
  5. Liberty Latin America Ltd (LILA) - 464,399 shares, 4.35% of the total portfolio. Shares reduced by 23.19%
New Purchase: Intra-Cellular Therapies Inc (ITCI)

Amia Capital LLP initiated holding in Intra-Cellular Therapies Inc. The purchase prices were between $12.31 and $34.31, with an estimated average price of $22. The stock is now traded at around $22.09. The impact to a portfolio due to this purchase was 0.41%. The holding were 30,144 shares as of .

New Purchase: Arvinas Inc (ARVN)

Amia Capital LLP initiated holding in Arvinas Inc. The purchase prices were between $33 and $54.5, with an estimated average price of $46.8. The stock is now traded at around $45.28. The impact to a portfolio due to this purchase was 0.39%. The holding were 10,815 shares as of .

New Purchase: Scholar Rock Holding Corp (SRRK)

Amia Capital LLP initiated holding in Scholar Rock Holding Corp. The purchase prices were between $9.63 and $17.14, with an estimated average price of $13.4. The stock is now traded at around $16.96. The impact to a portfolio due to this purchase was 0.25%. The holding were 22,962 shares as of .

New Purchase: Molecular Templates Inc (MTEM)

Amia Capital LLP initiated holding in Molecular Templates Inc. The purchase prices were between $11.31 and $18.26, with an estimated average price of $14.57. The stock is now traded at around $16.05. The impact to a portfolio due to this purchase was 0.22%. The holding were 18,836 shares as of .

New Purchase: Kezar Life Sciences Inc (KZR)

Amia Capital LLP initiated holding in Kezar Life Sciences Inc. The purchase prices were between $2.77 and $5.75, with an estimated average price of $4.07. The stock is now traded at around $5.17. The impact to a portfolio due to this purchase was 0.05%. The holding were 13,516 shares as of .

New Purchase: Cidara Therapeutics Inc (CDTX)

Amia Capital LLP initiated holding in Cidara Therapeutics Inc. The purchase prices were between $1.74 and $4.26, with an estimated average price of $3.02. The stock is now traded at around $2.99. The impact to a portfolio due to this purchase was 0.05%. The holding were 23,063 shares as of .

Sold Out: iShares J.P. Morgan USD Emerging Markets Bond ETF (EMB)

Amia Capital LLP sold out a holding in iShares J.P. Morgan USD Emerging Markets Bond ETF. The sale prices were between $85.11 and $115.88, with an estimated average price of $108.96.

Sold Out: iShares Inc. MSCI Chile (ECH)

Amia Capital LLP sold out a holding in iShares Inc. MSCI Chile. The sale prices were between $17.84 and $34.5, with an estimated average price of $28.55.

Sold Out: Qiagen NV (QGEN)

Amia Capital LLP sold out a holding in Qiagen NV. The sale prices were between $33.17 and $41.6, with an estimated average price of $36.78.

Sold Out: Lennar Corp (LEN.B)

Amia Capital LLP sold out a holding in Lennar Corp. The sale prices were between $21.81 and $56.21, with an estimated average price of $46.19.

Sold Out: Audentes Therapeutics Inc (BOLD)

Amia Capital LLP sold out a holding in Audentes Therapeutics Inc. The sale prices were between $59.83 and $60, with an estimated average price of $59.94.

Sold Out: Gilead Sciences Inc (GILD)

Amia Capital LLP sold out a holding in Gilead Sciences Inc. The sale prices were between $62.63 and $80.22, with an estimated average price of $68.92.



Here is the complete portfolio of Amia Capital LLP. Also check out:

1. Amia Capital LLP's Undervalued Stocks
2. Amia Capital LLP's Top Growth Companies, and
3. Amia Capital LLP's High Yield stocks
4. Stocks that Amia Capital LLP keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)